Africa-Press – South-Africa. Remgro is set to become the sole owner of Mediclinic’s Southern Africa division after another major shareholder announced a restructuring of its interests.
This will see investment giant Remgro, chaired by billionaire Johann Rupert, acquire full ownership of Mediclinic Southern Africa.
This comes as Remgro is on a roll, having recently received most of the regulatory approvals needed for its R13 billion transaction with Vodacom.
On Monday, 1 December 2025, Remgro announced that Investment Holding Limited (IHL) are proposing a restructuring of its interest in Mediclinic Holdings.
IHL is a Luxembourg-based wholly owned subsidiary of MSC Mediterranean Shipping Company Holding SA.
Remgro is a JSE-listed investment holding company with interests in financial services, packaging, medical services, and food and beverage producers. The company was started in the 1940s by businessman Anton Rupert, Johann Rupert’s father.
Today, it has stakes in many of South Africa’s most well-known companies, including RCL Foods, OUTsurance, FirstRand and the target of this announced restructuring, Mediclinic.
Mediclinic Southern Africa is the third-largest private healthcare provider in Southern Africa, by number of licensed beds.
Most of the company’s hospitals are acute, general hospitals providing specialist-led care by independent medical practitioners.
The company boasts 50 hospitals, 8,991 inpatient beds and over 21,400 employees across its network.
Remgro explained that IHL’s proposed restructuring would result in Remgro acquiring full ownership of Mediclinic Southern Africa.
IHL, in turn, would acquire full ownership of Hirslanden, the Swiss operations of Mediclinic Holdings.
“Remgro and IHL will then continue to hold their respective joint interests in the Middle East and Spire Healthcare Group businesses,” the company explained.
This restructuring is designed to enable both companies to take ownership in their respective home markets, which is expected to enhance their strategic focus and drive agility in response to market dynamics.
The company said it would enable both Remgro and IHL to tailor their respective clinical and operational strategies to local market dynamics and patient needs.
“This also better positions both businesses to unlock value through their strengthened local partnerships and brand presence, deepening trust with patients, clinicians, and regulators to drive sustainable growth through greater operational focus,” it said.
“The interests of Mediclinic Holdings employees have been and continue to be carefully considered, and the Potential Transaction will be structured with a view to ensuring continuity and stability for Mediclinic Holdings employees and patients.”
For More News And Analysis About South-Africa Follow Africa-Press
